IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 108

Article Submitted : 15207

Article Published : 6791

Total Authors : 18222

Total Reviewer : 664

Total Countries : 121

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Development and application of Liquid Chromatographic method for determination of Clofarabine in bulk and in parentral dosage forms
Authors Name: Dr.L.Satyanarayana , Dr.Sumalatha. Reddi
Download E-Certificate: Download
Author Reg. ID:
IJRTI_180040
Published Paper Id: IJRTI1803004
Published In: Volume 3 Issue 3, March-2018
DOI:
Abstract: Clofarabine is a purine nucleoside antimetabolite that is being studied in the treatment of cancer. It is marketed in the U.S. and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. Clofarabine is used in paediatrics to treat a type of leukaemia called relapsed or refractory acute lymphoblastic leukaemia (ALL), only after at least two other types of treatment have failed. It is not known if the drug extends life expectancy. Some investigations of effectiveness in cases of acute myeloid leukaemia (AML) and juvenile myelomonocytic leukaemia (JMML) have been carried out. Developing a accurate and precise alytical method for the estimation of Clofarabine in a sterile, product for intravenous (IV) infusion a is very challenging, due to the formation of drug-drug and drug-excipient interactions. The present study demonstrates the applicability of chromatographic method to develop a new, sensitive, single HPLC method for the quantitative determination of antifungal agents in freeze dried powder for injection pharmaceutical dosage form. Chromatographic separation active pharmaceutical ingredient was achieved by using a isocratic elution at a flow rate of 1.0 mL/min on Agilent Eclipse XDB Column (250mm×4.6 mm, 5μm particle size, 100Å pore size) at ambient temperature. The contents of the mobile phase were 3.48 gms of Di Potassium hydrogen ortho-phosphate (0.03M) in 1000 ml of water and by adjusting the pH to 2.5 with dilute ortho-phosphoric acid (mobile phase solvent-A) and acetonitrile (mobile phase solvent-B) in a isocratic mode in the ratio of 45:55 (v/v) of separation was used to resolute the Clofarabine. UV detection at 260 nm was employed to monitor the analytes. A linear response was observed for Clofarabine over the concentration range 2-24 μg/ mL. Limit of detection (LOD) and Limit of quantification (LOQ) for Clofarabine were found to be 0.004μg/mL, and 0.012μg/mL respectively.
Keywords: Clofarabine, Isocratic-HPLC, Casporan®, IV infusion
Cite Article: "Development and application of Liquid Chromatographic method for determination of Clofarabine in bulk and in parentral dosage forms ", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.3, Issue 3, page no.19 - 25, March-2018, Available :http://www.ijrti.org/papers/IJRTI1803004.pdf
Downloads: 000204841
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI1803004
Registration ID:180040
Published In: Volume 3 Issue 3, March-2018
DOI (Digital Object Identifier):
Page No: 19 - 25
Country: hyderabad, telangana, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI1803004
Published Paper PDF: https://www.ijrti.org/papers/IJRTI1803004
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner